| scholarly article | Q13442814 |
| P50 | author | Jeremy Farrar | Q15967402 |
| Marcel Wolbers | Q59593777 | ||
| Heiman Frank Louis Wertheim | Q30347958 | ||
| Peter W. Horby | Q37368815 | ||
| Cameron P. Simmons | Q37392993 | ||
| P2093 | author name string | Annette Fox | |
| Van Kinh Nguyen | |||
| Walter R Taylor | |||
| Duc Hien Nguyen | |||
| Nguyen Minh Hoa Le | |||
| Thi Hai Ninh Tran | |||
| Thi Khuong Pham | |||
| Thi Lien Nguyen | |||
| Thi Minh Lien Trinh | |||
| Vu Trung Nguyen | |||
| P2860 | cites work | Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses | Q24736969 |
| Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses | Q24791827 | ||
| Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody | Q27485050 | ||
| Viraemia in patients with naturally acquired dengue infection | Q27486148 | ||
| Relationship between Transmission Intensity and Incidence of Dengue Hemorrhagic Fever in Thailand | Q27486395 | ||
| Diagnostic Accuracy of NS1 ELISA and Lateral Flow Rapid Tests for Dengue Sensitivity, Specificity and Relationship to Viraemia and Antibody Responses | Q27487547 | ||
| Spatial Evaluation and Modeling of Dengue Seroprevalence and Vector Density in Rio de Janeiro, Brazil | Q27490244 | ||
| Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity | Q27860703 | ||
| Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses | Q27860800 | ||
| Pathogenesis of dengue: challenges to molecular biology | Q27860978 | ||
| Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
| A prospective study of dengue infections in Bangkok | Q28296365 | ||
| A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults | Q28475036 | ||
| Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas | Q29615132 | ||
| High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever | Q29618174 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua | Q33337347 | ||
| Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections | Q33342343 | ||
| Serotype-specific differences in clinical manifestations of dengue | Q33370483 | ||
| Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response | Q33378614 | ||
| Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji | Q33497472 | ||
| Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia | Q33638366 | ||
| Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever | Q33702837 | ||
| Invited commentary: Dengue lessons from Cuba | Q34086111 | ||
| Maternal antibody and viral factors in the pathogenesis of dengue virus in infants | Q35097469 | ||
| Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges | Q35119777 | ||
| Dengue diagnosis, advances and challenges | Q35633142 | ||
| Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control | Q37108706 | ||
| Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. | Q38871276 | ||
| Age and clinical dengue illness | Q38982873 | ||
| Epidemiologic studies on Dengue in Santiago de Cuba, 1997. | Q39038290 | ||
| Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. | Q39162218 | ||
| Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand | Q39591265 | ||
| Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement | Q40303277 | ||
| Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. | Q40463284 | ||
| Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. | Q40469577 | ||
| Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. | Q40506001 | ||
| Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever | Q40512486 | ||
| Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand | Q40539101 | ||
| Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand | Q40541720 | ||
| Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. | Q40563390 | ||
| High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis | Q40565852 | ||
| Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction | Q40610338 | ||
| Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia | Q40626033 | ||
| Risk factors in dengue shock syndrome. | Q40651443 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vietnam | Q881 |
| Dengue virus | Q476209 | ||
| hospitalization | Q3140971 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e967 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. | |
| P478 | volume | 5 |
| Q90560585 | A review of Dengvaxia®: development to deployment |
| Q36607295 | A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial |
| Q28114617 | An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting |
| Q41528130 | Bayesian methods for setting sample sizes and choosing allocation ratios in phase II clinical trials with time-to-event endpoints |
| Q26825708 | Can non-human primates serve as models for investigating dengue disease pathogenesis? |
| Q41928393 | Chymase is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients |
| Q33402055 | Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children |
| Q40133947 | Dengue Human Infection Models to Advance Dengue Vaccine Development |
| Q38640335 | Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features |
| Q43047474 | Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features |
| Q38386336 | Dengue human infection models to advance dengue vaccine development |
| Q35692481 | Dengue in adults admitted to a referral hospital in Hanoi, Vietnam |
| Q34766802 | Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters |
| Q96773997 | Dengue virus co-infections with multiple serotypes do not result in a different clinical outcome compared to mono-infections |
| Q35068058 | Dengue virus in sub-tropical northern and central Viet Nam: population immunity and climate shape patterns of viral invasion and maintenance |
| Q35119732 | Dengue virus type 2 (DENV2)-induced oxidative responses in monocytes from glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD normal subjects |
| Q35276730 | Dengue--quo tu et quo vadis? |
| Q92746405 | Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue |
| Q27882968 | Drivers of Inter-individual Variation in Dengue Viral Load Dynamics |
| Q59355813 | Drug repurposing of quinine as antiviral against dengue virus infection |
| Q36756643 | Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity |
| Q34761908 | Evaluation of host and viral factors associated with severe dengue based on the 2009 WHO classification |
| Q31156754 | First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies |
| Q33430763 | Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity |
| Q33588528 | Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam. |
| Q28476805 | Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue |
| Q36396156 | Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo |
| Q36026358 | Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections |
| Q56395792 | Methods to discriminate primary from secondary dengue during acute symptomatic infection |
| Q27869771 | Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak |
| Q47548302 | Molecular epidemiology of dengue viruses in three provinces of Lao PDR, 2006-2010. |
| Q55648073 | NS1 Antigenemia and Viraemia Load: Potential Markers of Progression to Dengue Fatal Outcome? |
| Q59350268 | Nonhuman primate models of human viral infections |
| Q39258872 | Pathogenesis of vascular leak in dengue virus infection |
| Q91704346 | Phenotype and functionality of follicular helper T cells in patients with acute dengue infection |
| Q57061690 | Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection |
| Q35905785 | Revealing the molecular signatures of host-pathogen interactions. |
| Q39302764 | Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar |
| Q26314515 | Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitória, Brazil |
| Q97549435 | Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients |
| Q35757022 | Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses |
| Q34990697 | Suppression of virus specific immune responses by IL-10 in acute dengue infection |
| Q33414009 | T-cell immunity to infection with dengue virus in humans |
| Q42987133 | The dengue human challenge model: has the time come to accept this challenge? |
| Q24290790 | The effects of weather and climate change on dengue |
| Q37165020 | The outcomes of patients with severe dengue admitted to intensive care units |
| Q27011587 | Understanding the dengue viruses and progress towards their control |
| Q37184768 | Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles |
| Q36082908 | Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis |
| Q92778271 | Whole genome sequencing and genetic variations in several dengue virus type 1 strains from unusual dengue epidemic of 2017 in Vietnam |
Search more.